microdosing tirzepatide to maintain weight loss is an emerging approach for supporting metabolic and hormonal health. By using smaller, carefully titrated doses, some patients may experience improved insulin sensitivity, reduced inflammation, and better metabolic regulation. For Microdosing Tirzepatide: What You Need

FDA-Approved Weight-Loss Medications The contrast between AOD-9604 and FDA-approved anti-obesity pharmacotherapies is stark

Sublingual vitamin B12 compared to intramuscular injection in patients with type 2 diabetes treated with metformin: a randomized trial

360 Hwang, Y.-C

You should not use Wegovy pills if you: Have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Are pregnant or planning to become pregnant (semaglutide should be discontinued at least 2 months before a planned pregnancy) Have a history of serious hypersensitivity reactions to semaglutide Are currently taking another semaglutide-containing product (Ozempic, Rybelsus, injectable Wegovy) or another GLP-1 receptor agonist Your provider will also consider your full medication list and medical history before issuing a prescription

Not suitable for patients with a personal or family history of medullary thyroid carcinoma